Genitourinary cancers: Clinical insights into trial data
Editorial board member Axel Merseburger discusses the clinical implications of key genitourinary cancer abstracts presented at the 2021 ASCO Annual Meeting, including the KEYNOTE-564 and VISION trials, as well as brain metastases data from CheckMate 920 and updates on several enfortumab vedotin studies (6:40).
00:00 - Introduction
00:29 - Renal cell cancer studies
03:04 - Prostate cancer studies
04:12 - Bladder cancer studies